Volkswagen AG will reduce investment spending at its main passenger-car brand by 1 billion euros ($1.1 billion) a year and speed up other cost cuts in the wake of a diesel emissions-cheating scandal.
Toyota Motor Corp. said it set out to match the performance of diesel engines in developing its new Prius, as analysts predict gasoline-electric hybrids to benefit from Volkswagen AG’s emissions-rigging scandal.
SUV deliveries surged last month in China to become the only passenger-vehicle category to register a sales increase, underscoring how consumer preferences are veering away from traditional lower-riding sedans amid a sharp slowdown.
Tesla has a shiny new workspace. This 11-acre facility is where cars will be assembled and tested before delivery across Europe. The new plant, in Tilburg, Netherlands, is actually a major expansion of an assembly space Tesla opened just two years ago. Tesla needs the extra room as it launches the new Model X SUV and tries to expand from about 50,000 deliveries worldwide this year to 500,000 by 2020. When the new digs are fully up and running, about 450 cars will roll off the line each week. Photographs by Jasper Juinen for Bloomberg
Passenger-vehicle sales in China expanded at the slowest pace since 2012 so far this year, underlining the slump in demand that prompted the government to cut a tax on car purchases to revive demand in the world’s biggest auto market.
Singapore Airlines Ltd. is poised to regain the title of world’s longest flight with a nonstop service to New York.
A dispute between Malaysia’s attorney general and central bank over investigations into a debt-ridden state investment company has become increasingly public, highlighting tensions over the matter ahead of the resumption of the country’s parliament.
Yorick van Slingelandt, the head of Moelis & Co.’s Middle East North Africa business, is taking up an expanded role at the merger-advisory firm’s European business and will move to London, according to an internal memo seen by Bloomberg News.
It began as idle chatter between two employees in their 20s exploring the intersection of lucre and idealism. Both had read about the practice of investing in companies that seek to do good and still make a profit.
In the year since Treasuries suddenly went haywire in the bond market’s version of the “flash crash,” unusual bursts of volatility have become more common than ever before.
On "Morning Must Read," Tom Keene recaps the op-ed pieces and analyst notes that provide insight into today's headlines. Starwood Capital Group Chairman and CEO Barry Sternlicht also speaks on "Bloomberg ‹GO›." (Source: Bloomberg)
Starwood Capital Group Chairman and CEO Barry Sternlicht discusses Fed policy. He speaks on "Bloomberg ‹GO›." (Source: Bloomberg)
U.S. stock-index futures tracked losses in global equities after weaker-than-expected Chinese import data reignited growth concerns.
Taming inflation remains a “strategic” goal of Russia’s central bank, whose governor said she’s “fairly sure” of reaching a 4 percent target for price growth in 2017 even after oil-price weakness dragged down the ruble.
London School of Economics Professor Christopher Pissarides discusses the lack of global inflation, why fiscal stimulus is not the answer at the moment and market expectations for tighter monetary policy. He speaks on "Bloomberg Surveillance." (Source: Bloomberg)
Brookfield Asset Management Inc., Canada’s largest alternative asset manager, will create a new publicly traded subsidiary by spinning off a portion of its private-equity arm through a special $500 million dividend.
The hedge fund offers expensive loans to tribes with limited options.
Richard Rainwater, the Texas investor who helped the Bass family turn a $50 million oil inheritance into a reputed $5 billion fortune, has died. He was 71.
45 Park Place developer Sharif El-Gamal plans a 70-story residential tower, with amenities to evoke a five-star hotel.
An expected pickup in property-price growth and an expanding buy-to-let mortgage market aren’t undermining U.K. financial stability, the Bank of England said.
Johnson & Johnson, the world’s biggest maker of health-care products, beat analysts’ estimates for third-quarter profit, though sales were slightly weaker than expected for key drugs such as Remicade.
Johnson & Johnson, the world’s biggest maker of health-care products, said its board approved a plan to buy back as much as $10 billion in shares, double the amount it budgeted last year.
For the first time, a consortium of top U.S. cancer hospitals will provide patients with guidance about the cost of drugs used in their treatment, helping address a concern for many people undergoing a major medical event -- what the financial repercussions of their condition are.
GHO Capital Partners, a London-based investor in health-care assets, is buying specialist testing company DNA Diagnostics Center Inc. of the U.S. for 104 million euros ($118 million), according to a statement from the company.
Fullerton Healthcare Corp., a provider of medical services to corporate workers in Asia, is planning an initial public offering in Singapore, people with knowledge of the matter said.